HK Stock MarketDetailed Quotes

02269 WUXI BIO

Watchlist
  • 12.740
  • -0.160-1.24%
Not Open Apr 25 16:09 CST
54.26BMarket Cap14.46P/E (TTM)

WUXI BIO Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
(Q6)Jun 30, 2019
Turnover
11.56%17.03B
17.84%8.49B
48.38%15.27B
63.53%7.21B
83.35%10.29B
126.67%4.41B
40.88%5.61B
20.97%1.94B
57.18%3.98B
52.42%1.61B
Operating income
11.56%17.03B
17.84%8.49B
48.38%15.27B
63.53%7.21B
83.35%10.29B
126.67%4.41B
40.88%5.61B
20.97%1.94B
57.18%3.98B
52.42%1.61B
Cost of sales
-19.45%-10.21B
-30.01%-4.93B
-56.46%-8.54B
-79.78%-3.79B
-77.34%-5.46B
-82.39%-2.11B
-32.46%-3.08B
-23.58%-1.16B
-53.28%-2.32B
-46.34%-936.06M
Operating expenses
-19.45%-10.21B
-30.01%-4.93B
-56.46%-8.54B
-79.78%-3.79B
-77.34%-5.46B
-82.39%-2.11B
-32.46%-3.08B
-23.58%-1.16B
-53.28%-2.32B
-46.34%-936.06M
Gross profit
1.55%6.83B
4.32%3.56B
39.25%6.72B
48.60%3.41B
90.64%4.83B
191.73%2.3B
52.70%2.53B
17.33%787.31M
62.99%1.66B
61.80%671.01M
Selling expenses
-80.47%-294.01M
-57.06%-105.39M
-30.70%-162.91M
-11.18%-67.1M
-32.02%-124.65M
-24.55%-60.36M
-22.49%-94.42M
-83.94%-48.46M
-81.66%-77.08M
-32.10%-26.35M
Administrative expenses
-17.78%-1.5B
-30.67%-679.64M
-44.94%-1.27B
-49.61%-520.11M
-71.27%-875.93M
-70.93%-347.64M
-39.25%-511.44M
-35.85%-203.38M
-61.29%-367.29M
-71.92%-149.71M
Research and development expenses
-15.09%-785.82M
-25.93%-341.44M
-36.13%-682.82M
-135.00%-271.13M
-65.14%-501.58M
7.27%-115.38M
-16.98%-303.73M
-14.02%-124.41M
-53.38%-259.65M
-94.10%-109.12M
Impairment and provision
-23.77%-319.97M
-86.05%-131.8M
-65.02%-258.53M
46.80%-70.84M
-29.41%-156.67M
-135.33%-133.17M
-1,669.39%-121.06M
-492.22%-56.59M
87.77%-6.84M
51.16%-9.56M
-Other impairment is provision
-23.77%-319.97M
-86.05%-131.8M
-65.02%-258.53M
46.80%-70.84M
-29.41%-156.67M
-135.33%-133.17M
-1,669.39%-121.06M
-492.22%-56.59M
87.77%-6.84M
51.16%-9.56M
Special items of operating profit
-62.73%399.54M
-34.84%305.43M
24.33%1.07B
6.83%468.77M
71.24%862.24M
17.28%438.81M
150.03%503.54M
167.12%374.15M
-6.48%201.39M
163.46%140.07M
Operating profit
-20.10%4.33B
-11.68%2.61B
34.47%5.42B
42.02%2.95B
101.03%4.03B
185.35%2.08B
74.52%2.01B
41.11%728.61M
55.80%1.15B
81.13%516.35M
Financing cost
-146.17%-158.49M
-247.82%-78.82M
-64.28%-64.38M
-8.56%-22.66M
8.29%-39.19M
6.83%-20.87M
-117.96%-42.73M
-385.90%-22.41M
---19.61M
---4.61M
Share of profits of associates
----
----
----
----
----
----
184.39%2.63M
-456.31%-1.1M
---3.12M
--309K
Earning before tax
-22.10%4.17B
-13.69%2.53B
34.18%5.36B
42.36%2.93B
103.13%3.99B
191.90%2.06B
74.48%1.97B
37.70%705.11M
52.72%1.13B
79.62%512.05M
Tax
25.34%-603.18M
38.13%-191.12M
-66.73%-807.87M
-76.07%-308.91M
-77.44%-484.54M
-785.41%-175.45M
-134.80%-273.07M
140.92%25.6M
-8.43%-116.3M
-76.21%-62.56M
After-tax profit from continuing operations
-21.52%3.57B
-10.81%2.34B
29.68%4.55B
39.22%2.62B
107.28%3.51B
157.67%1.88B
67.54%1.69B
62.57%730.7M
60.25%1.01B
80.10%449.48M
Earning after tax
-21.52%3.57B
-10.81%2.34B
29.68%4.55B
39.22%2.62B
107.28%3.51B
157.67%1.88B
67.54%1.69B
62.57%730.7M
60.25%1.01B
80.10%449.48M
Minority profit
31.84%170.9M
-17.38%71.19M
7.92%129.62M
112.02%86.16M
3,053.97%120.1M
851.30%40.64M
209.80%3.81M
-869.35%-5.41M
-2,630.71%-3.47M
---558K
Profit attributable to shareholders
-23.09%3.4B
-10.59%2.27B
30.45%4.42B
37.62%2.54B
100.63%3.39B
150.25%1.84B
66.59%1.69B
63.57%736.11M
60.77%1.01B
80.33%450.04M
Basic earnings per share
-22.64%0.82
-9.84%0.55
30.86%1.06
38.64%0.61
88.37%0.81
131.58%0.44
59.26%0.43
-48.65%0.19
-48.08%0.27
76.19%0.37
Diluted earnings per share
-23.76%0.77
-10.34%0.52
31.17%1.01
38.10%0.58
92.50%0.77
133.33%0.42
60.00%0.4
-47.06%0.18
-47.92%0.25
78.95%0.34
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
Deloitte & Touche Tohmatsu Certified Public Accountants
--
Deloitte & Touche Tohmatsu Certified Public Accountants
--
Deloitte & Touche Tohmatsu Certified Public Accountants
--
Deloitte & Touche Tohmatsu Certified Public Accountants
--
Deloitte & Touche Tohmatsu Certified Public Accountants
--
(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020(FY)Dec 31, 2019(Q6)Jun 30, 2019
Turnover 11.56%17.03B17.84%8.49B48.38%15.27B63.53%7.21B83.35%10.29B126.67%4.41B40.88%5.61B20.97%1.94B57.18%3.98B52.42%1.61B
Operating income 11.56%17.03B17.84%8.49B48.38%15.27B63.53%7.21B83.35%10.29B126.67%4.41B40.88%5.61B20.97%1.94B57.18%3.98B52.42%1.61B
Cost of sales -19.45%-10.21B-30.01%-4.93B-56.46%-8.54B-79.78%-3.79B-77.34%-5.46B-82.39%-2.11B-32.46%-3.08B-23.58%-1.16B-53.28%-2.32B-46.34%-936.06M
Operating expenses -19.45%-10.21B-30.01%-4.93B-56.46%-8.54B-79.78%-3.79B-77.34%-5.46B-82.39%-2.11B-32.46%-3.08B-23.58%-1.16B-53.28%-2.32B-46.34%-936.06M
Gross profit 1.55%6.83B4.32%3.56B39.25%6.72B48.60%3.41B90.64%4.83B191.73%2.3B52.70%2.53B17.33%787.31M62.99%1.66B61.80%671.01M
Selling expenses -80.47%-294.01M-57.06%-105.39M-30.70%-162.91M-11.18%-67.1M-32.02%-124.65M-24.55%-60.36M-22.49%-94.42M-83.94%-48.46M-81.66%-77.08M-32.10%-26.35M
Administrative expenses -17.78%-1.5B-30.67%-679.64M-44.94%-1.27B-49.61%-520.11M-71.27%-875.93M-70.93%-347.64M-39.25%-511.44M-35.85%-203.38M-61.29%-367.29M-71.92%-149.71M
Research and development expenses -15.09%-785.82M-25.93%-341.44M-36.13%-682.82M-135.00%-271.13M-65.14%-501.58M7.27%-115.38M-16.98%-303.73M-14.02%-124.41M-53.38%-259.65M-94.10%-109.12M
Impairment and provision -23.77%-319.97M-86.05%-131.8M-65.02%-258.53M46.80%-70.84M-29.41%-156.67M-135.33%-133.17M-1,669.39%-121.06M-492.22%-56.59M87.77%-6.84M51.16%-9.56M
-Other impairment is provision -23.77%-319.97M-86.05%-131.8M-65.02%-258.53M46.80%-70.84M-29.41%-156.67M-135.33%-133.17M-1,669.39%-121.06M-492.22%-56.59M87.77%-6.84M51.16%-9.56M
Special items of operating profit -62.73%399.54M-34.84%305.43M24.33%1.07B6.83%468.77M71.24%862.24M17.28%438.81M150.03%503.54M167.12%374.15M-6.48%201.39M163.46%140.07M
Operating profit -20.10%4.33B-11.68%2.61B34.47%5.42B42.02%2.95B101.03%4.03B185.35%2.08B74.52%2.01B41.11%728.61M55.80%1.15B81.13%516.35M
Financing cost -146.17%-158.49M-247.82%-78.82M-64.28%-64.38M-8.56%-22.66M8.29%-39.19M6.83%-20.87M-117.96%-42.73M-385.90%-22.41M---19.61M---4.61M
Share of profits of associates ------------------------184.39%2.63M-456.31%-1.1M---3.12M--309K
Earning before tax -22.10%4.17B-13.69%2.53B34.18%5.36B42.36%2.93B103.13%3.99B191.90%2.06B74.48%1.97B37.70%705.11M52.72%1.13B79.62%512.05M
Tax 25.34%-603.18M38.13%-191.12M-66.73%-807.87M-76.07%-308.91M-77.44%-484.54M-785.41%-175.45M-134.80%-273.07M140.92%25.6M-8.43%-116.3M-76.21%-62.56M
After-tax profit from continuing operations -21.52%3.57B-10.81%2.34B29.68%4.55B39.22%2.62B107.28%3.51B157.67%1.88B67.54%1.69B62.57%730.7M60.25%1.01B80.10%449.48M
Earning after tax -21.52%3.57B-10.81%2.34B29.68%4.55B39.22%2.62B107.28%3.51B157.67%1.88B67.54%1.69B62.57%730.7M60.25%1.01B80.10%449.48M
Minority profit 31.84%170.9M-17.38%71.19M7.92%129.62M112.02%86.16M3,053.97%120.1M851.30%40.64M209.80%3.81M-869.35%-5.41M-2,630.71%-3.47M---558K
Profit attributable to shareholders -23.09%3.4B-10.59%2.27B30.45%4.42B37.62%2.54B100.63%3.39B150.25%1.84B66.59%1.69B63.57%736.11M60.77%1.01B80.33%450.04M
Basic earnings per share -22.64%0.82-9.84%0.5530.86%1.0638.64%0.6188.37%0.81131.58%0.4459.26%0.43-48.65%0.19-48.08%0.2776.19%0.37
Diluted earnings per share -23.76%0.77-10.34%0.5231.17%1.0138.10%0.5892.50%0.77133.33%0.4260.00%0.4-47.06%0.18-47.92%0.2578.95%0.34
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--
Auditor Deloitte & Touche Tohmatsu Certified Public Accountants--Deloitte & Touche Tohmatsu Certified Public Accountants--Deloitte & Touche Tohmatsu Certified Public Accountants--Deloitte & Touche Tohmatsu Certified Public Accountants--Deloitte & Touche Tohmatsu Certified Public Accountants--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg